Cetadiol
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | Androst-5-ene-3β,16α-diol; 3β,16α-Dihydroxy-5-androstene |
| Routes of administration |
Oral |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| KEGG | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H30O2 |
| Molar mass | 290.447 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Cetadiol, also known as androst-5-ene-3β,16α-diol, is a drug described as a "steroid tranquilizer" which was briefly investigated as a treatment for alcoholism in the 1950s. It is an androstane steroid and analogue of 5-androstenediol (androst-5-ene-3β,17β-diol) and 16α-hydroxy-DHEA (androst-5-ene-3β,16α-diol-17-one), but showed no androgenic or myotrophic activity in animal bioassays. The drug was reported in 1956 and studied until 1958.
Chemistry
See also: List of neurosteroids
See also
- Androstadienol (androsta-5,16-dien-3β-ol)
- Androstenol (5α-androst-16-en-3α-ol)
- 4-Androstadienol (PH94B; Aloradine)
- Cyclopregnol